Genetic Effects on Baseline Values of C-Reactive Protein and Serum Amyloid A Protein: A Comparison of Monozygotic and Dizygotic Twins

Clinical Chemistry

Volumn 50, Issue 1, 2004, Pages 130-134

  MacGregor, Alex J ^a   Gallimore, J Ruth ^b   Spector, Tim D ^a   Pepys, Mark B ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SERUM AMYLOID A;

ADULT; AGED; ARTICLE; AUTOANALYSIS; BLOOD ANALYSIS; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIZYGOTIC TWINS; FEMALE; HEREDITY; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; MICROPARTICLE ENZYME IMMUNOASSAY; MONOZYGOTIC TWINS; NORMAL HUMAN; POPULATION RESEARCH; SMOKING; STANDARDIZATION; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AUTOANALYSIS; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; REFERENCE VALUES; SERUM AMYLOID A PROTEIN; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; WORLD HEALTH ORGANIZATION;

EID: 1642533465     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.028258     Document Type: Article

References (29)

1. Pepys MB. The acute phase response and C-reactive protein. In: Warrell DA, Cox TM, Firth JD, Benz EJ Jr, eds. Oxford textbook of medicine, 4th ed., Vol. 2. Oxford: Oxford University Press, 2003:150-6.
2. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981;117:13-23.
3. Hutchinson WL, Koenig W, Fröhlich M, Sund M, Lowe GDO, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000;46:934-8.
4. Rifai N, Ridker PM. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem 2003;49:666-9.
5. Imhof A, Fröhlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, et al. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem 2003;49:669-72.
6. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
7. Pepys MB, Hirschfield GM. C-Reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
8. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
9. Wilkins J, Gallimore JR, Tennent GA, Hawkins PN, Limburg PC, van Rijswijk MH, et al. Rapid automated enzyme immunoassay of serum amyloid A. Clin Chem 1994;40:1284-90.
10. Wilkins J, Gallimore JR, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 1998;44:1358-61.
11. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 1999;10:S9-12.
12. Kayaba K, Ishikawa S, Gotoh T, Nago N, Kajii E, Nakamura Y, et al. Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study. The Jichi Medical School Cohort Study at Yamato, 1993-1998. Jpn Circ J 2000;64:303-8.
13. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001;47:444-50.
14. Koenig W, Sund M, Fröhlich M, Löwel H, Hutchinson WL, Pepys MB. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time. The MONICA Augsburg Studies, 1984 and 1987. Am J Epidemiol 2003;158:357-64.
15. van Leeuwen MA, van Rijswijk MH, Sluiter WJ, van Riel PLCM, Kuper IH, van de Putte LBA, et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol 1997;24:20-7.
16. Fagan EA, Dyck RF, Maton PN, Hodgson HJF, Chadwick VS, Pepys MB. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982;12:351-60.
17. Retterstol L, Eikvar L, Berg K. A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 2003;169:279-82.
18. Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D. Genetic influences on osteoarthritis in women: a twin study. BMJ 1996;312:940-3.
19. Andrew T, Hart DJ, Snieder H, de Lange M, Spector TD, MacGregor AJ. Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res 2001;4:464-77.
20. WHO Expert Committee on Biological Standardization, 37th Report. WHO Technical Report Series 760. Geneva, Swwitzerland: WHO, 1987;21-2.
21. Poole S, Walker D, Gaines Das RE, Gallimore JR, Pepys MB. The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods 1998;214:1-10.
22. Neale MC, Cardon LR. Methodology for genetic studies of twins and families. Dordrecht, The Netherlands: Kluwer Academic, 1992:496pp.
23. Danesh J, Muir J, Wong Y-K, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 1999;20:954-9.
24. Phillips DIW. Twin studies in medical research: can they tell us whether diseases are genetically determined? Lancet 1993;341:1008-9.
25. Berger P, McConnell JP, Nunn M, Kornman KS, Sorrell J, Stephenson K, et al. C-Reactive protein levels are influenced by common IL-1 gene variations. Cytokine 2002;17:171-4.
26. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002;53:1029-34.
27. Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002;162:217-9.
28. Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP. Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun 2002;3:14-9.
29. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, et al. A polymorphism in the human CRP gene influences basal and stimulated CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Atherosclerosis 2003;168:192.